Development Pipeline
RTP801i-14
AKIi-5
AHLi-11
BT16
CTi-1
PAb-W4
Letter from the CEO
Company Profile
Management
Board of Directors
Medical Advisory Board
Mission, Vision and Values
Code of Business and Ethics
Partners
News
Careers
Overview
Code of Business and Ethics
News
Overview
R&D Collaborations
Target Discovery
SiRNA
About Us
Product Candidates
Research & Development
Investor Relations
Contact
Development Pipeline
RTP801i-14
AKIi-5
AHLi-11
BT16
CTi-1
PAb-W4
Letter from the CEO
Company Profile
Management
Board of Directors
Medical Advisory Board
Mission, Vision and Values
Code of Business and Ethics
Partners
News
Careers
Overview
Code of Business and Ethics
News
Overview
R&D Collaborations
Target Discovery
SiRNA
About Us
Product Candidates
Research & Development
Investor Relations
Contact
Pipeline
Product:
RTP801i-14
Disease:
Age-related Macular Degeneration (AMD)
Technology:
siRNA
Partner:
Pfizer
Product:
AKIi-5
Disease:
Acute Renal Failure (ARF)
Technology:
siRNA
Product:
AHLi-11
Disease:
Acute Hearing Loss
Technology:
siRNA
Product:
BT16
Disease:
Dyslipidemia and Metabolic
Technology:
Small Molecule
Product:
CTi-1
Disease:
Chronic obstructive pulmonary disease (COPD)
Technology:
siRNA
Product:
PAb-W4
Disease:
Chronic Renal Failure
Technology:
Antibody
Product:
Pipeline siRNA
Disease:
Others
Technology : siRNA
Pipeline
RTP801i-14
AKIi-5
AHLi-11
BT16
CTi-1
PAb-W4
Home
Products
Contact
©2007 Quark Pharmaceuticals, Inc.